Cargando…

Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients

INTRODUCTION: Pulmonary exacerbations (PEs) cause significant morbidity and can severely impact disease progression in cystic fibrosis (CF) lung disease, especially in patients who suffer from recurrent PEs. The assessments able to predict a future PE or a recurrent PE are limited. We hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojewodka, Gabriella, De Sanctis, Juan B., Bernier, Joanie, Bérubé, Julie, Ahlgren, Heather G., Gruber, Jim, Landry, Jennifer, Lands, Larry C., Nguyen, Dao, Rousseau, Simon, Benedetti, Andrea, Matouk, Elias, Radzioch, Danuta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922941/ https://www.ncbi.nlm.nih.gov/pubmed/24533110 http://dx.doi.org/10.1371/journal.pone.0088567

Ejemplares similares

C-Reactive Protein in Stable Cystic Fibrosis: An Additional Indicator of Clinical Disease Activity and Risk of Future Pulmonary Exacerbations
por: Matouk, Elias, et al.
Publicado: (2016)

Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
por: Ahlgren, Heather G., et al.
Publicado: (2015)

Corticosteroid-resistant inflammatory signalling in Pseudomonas-infected bronchial cells
por: Mizutani, Mirai, et al.
Publicado: (2017)

Ceramide in Cystic Fibrosis: A Potential New Target for Therapeutic Intervention
por: Wojewodka, Gabriella, et al.
Publicado: (2011)

Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses
por: LaFayette, Shantelle L., et al.
Publicado: (2015)

The protective effect of fenretinide against allergic asthma
por: Kanagaratham, Cynthia, et al.
Publicado: (2010)

Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway
por: Lachance, Claude, et al.
Publicado: (2013)

High-Dose Ibuprofen in Cystic Fibrosis
por: Lands, Larry C., et al.
Publicado: (2010)

Infection prevention and control in cystic fibrosis: One size fits all?
por: Lands, Larry C.
Publicado: (2020)

Computed tomography reveals hypertrophic remodelling of the diaphragm in cystic fibrosis but not in COPD
por: Ostadan, Fatemeh, et al.
Publicado: (2023)

Editorial: Quo Vadis Lipid Mediators – Lipid Mediators Implication in Inflammation and Chronic Inflammatory Diseases
por: Radzioch, Danuta, et al.
Publicado: (2021)

Rhinovirus Load Is High despite Preserved Interferon-β Response in Cystic Fibrosis Bronchial Epithelial Cells
por: Dauletbaev, Nurlan, et al.
Publicado: (2015)

Functionally Relevant Differences in Plasma Fatty Acid Composition and Expression of Cytotoxic and Inhibitory NK Cell Receptors between Healthy Young and Healthy Elder Adults
por: De Sanctis, Juan Bautista, et al.
Publicado: (2020)

Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses
por: Singh, Amrit, et al.
Publicado: (2013)

Re-opening the pediatric pulmonary function laboratory during the ongoing COVID-19 pandemic
por: Lands, Larry C.
Publicado: (2022)

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023)

Impact of exacerbations of cystic fibrosis on muscle strength
por: Burtin, Chris, et al.
Publicado: (2013)

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations
por: Merjaneh, Lina, et al.
Publicado: (2020)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice
por: Divangahi, Maziar, et al.
Publicado: (2009)

Probability
por: Pitman, Jim
Publicado: (1993)

Probability /
por: Pitman, Jim
Publicado: (1993)

Rhinovirus C and Respiratory Exacerbations in Children with Cystic Fibrosis
por: de Almeida, Marina B., et al.
Publicado: (2010)

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
por: Sawant, Akhil, et al.
Publicado: (2018)

Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
por: Wojsyk-Banaszak, I., et al.
Publicado: (2019)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Clinical Relevance of KRAS in Human Cancers
por: Jančík, Sylwia, et al.
Publicado: (2010)

LasR-deficient Pseudomonas aeruginosa variants increase airway epithelial mICAM-1 expression and enhance neutrophilic lung inflammation
por: Hennemann, Lisa C., et al.
Publicado: (2021)

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF)
por: Hebestreit, Helge, et al.
Publicado: (2021)

Elementary probability with applications
por: Rabinowitz, Larry
Publicado: (2016)

Elementary probability with applications
por: Rabinowitz, Larry
Publicado: (2004)

BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
por: Schultz, Andre, et al.
Publicado: (2023)

Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis
por: Widger, John, et al.
Publicado: (2012)

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis
por: Lavie, Moran, et al.
Publicado: (2011)

Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis
por: DiMango, Emily, et al.
Publicado: (2014)

Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis
por: Rajagopala, Srinivas, et al.
Publicado: (2015)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Daily spirometry in an acute exacerbation of adult cystic fibrosis patients
por: Stephen, Michael J, et al.
Publicado: (2017)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis
por: Asner, Sandra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k04b5cd0fg7fbu2q2q4thl5nui